BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35370653)

  • 21. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
    Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.
    Yeboah-Korang A; Louissaint J; Tsung I; Prabhu S; Fontana RJ
    Drug Saf; 2020 Apr; 43(4):371-377. PubMed ID: 31916081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
    Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH;
    Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method.
    Teschke R; Danan G
    Medicines (Basel); 2024 Apr; 11(4):. PubMed ID: 38667507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM.
    Qin FL; Sang GY; Zou XQ; Cheng DH
    Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
    Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
    Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A revised electronic version of RUCAM for the diagnosis of DILI.
    Hayashi PH; Lucena MI; Fontana RJ; Bjornsson ES; Aithal GP; Barnhart H; Gonzalez-Jimenez A; Yang Q; Gu J; Andrade RJ; Hoofnagle JH
    Hepatology; 2022 Jul; 76(1):18-31. PubMed ID: 35014066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 May; ():. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
    Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
    Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
    Mullins C; Beaulac K; Sylvia L
    Ann Pharmacother; 2020 Jun; 54(6):526-532. PubMed ID: 31786964
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis.
    Moreno-Torres M; Quintás G; Martínez-Sena T; Jover R; Castell JV
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Drug-Induced Liver Injury.
    Teschke R
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.
    Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M
    Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM.
    Kobayashi T; Iwaki M; Nogami A; Yoneda M
    J Clin Transl Hepatol; 2023 Oct; 11(5):1239-1245. PubMed ID: 37577239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.
    Teschke R; Uetrecht J
    Ann Transl Med; 2021 Apr; 9(8):730. PubMed ID: 33987428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.